Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.52 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.50 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.50 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.50 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.50 |
| ▸ | MYC | P01106 | 1/20 | 0.49 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.49 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.47 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.47 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.47 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.47 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 2/20 | 0.47 |
| ▸ | GALR3 | O60755 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30722862 | 1.00 | KDM4E (0.59) | KDM4EGLADGAT1AKR1C2AKR1C1 | |
| SCHEMBL875504 | 0.83 | ALDH1A1 (0.53) | KDM4EGLADGAT1AKR1C2AKR1C1 | |
| SCHEMBL156346 | 0.83 | DGAT1 (0.68) | KDM4EGLADGAT1MYCNR4A1 | |
| SCHEMBL3652414 | 0.81 | AKR1C3 (0.54) | KDM4EGLAAKR1C2AKR1C1AKR1C3 | |
| SCHEMBL10082 | 0.81 | DGAT1 (0.50) | KDM4EGLADGAT1MYCNR4A1 | |
| Hydrochloric Acid SCHEMBL2349044 | 0.81 | DGAT1 (0.66) | KDM4EGLADGAT1MYCNR4A1 | |
| SCHEMBL181200 | 0.81 | ALDH1A1 (0.52) | KDM4EGLADGAT1AKR1C2AKR1C1 | |
| SCHEMBL29401981 | 0.81 | ALDH1A1 (0.52) | KDM4EGLADGAT1AKR1C2AKR1C1 | |
| SCHEMBL30374539 | 0.81 | DGAT1 (0.50) | KDM4EGLADGAT1MYCNR4A1 | |
| SCHEMBL351693 | 0.81 | DGAT1 (0.71) | KDM4EGLADGAT1CES2GALR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 698 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111732594-B | Preparation method of fluxaparide | 苏州富士莱医药股份有限公司 | 2022-03-04 | — | — | CN | claimed |
| WO-2022036940-A1 | PREPARATION METHOD FOR FLUZOPARIB | 苏州富士莱医药股份有限公司 | 2022-02-24 | — | — | WO | claimed |
| CN-110229537-B | Flame-retardant plastic-wood composite material with excellent water boiling resistance and preparation method thereof | 黄山美森新材料科技股份有限公司 | 2021-05-11 | — | — | CN | claimed |
| CN-111732594-A | Preparation method of fluxaparide | 苏州富士莱医药股份有限公司 | 2020-10-02 | — | — | CN | claimed |
| CN-1244531-C | Process for producing 5-bromo-2-fluorobenzoic boric acid | AMERICAN CYANAMID CO (US) | 2006-03-08 | — | — | CN | claimed |
| CN-1403430-A | Process for producing 5-bromo-2-fluorobenzoic boric acid | AMERICAN CYANAMID CO (US) | 2003-03-19 | — | — | CN | claimed |
| CN-1087743-C | Method for preparing 5-bromo-2-fluorobenzeneboronic acid | AMERICAN CYANAMID CO (US) | 2002-07-17 | — | — | CN | claimed |
| CN-1168887-A | Method for preparing 5-bromo-2-fluorobenzeneboronic acid | AMERICAN CYANAMID CO (US) | 1997-12-31 | — | — | CN | claimed |
| EP-4725946-A1 | IRAK4 DEGRADATION AGENT AND USE THEREOF | Guangzhou Unirise Pharmaceutical Co., Ltd. (CN) | 2026-04-15 | — | — | EP | disclosed |
| EP-3921310-B1 | NEW N-BENZYL-2-PHENOXYBENZAMIDE DERIVATIVES AS PROSTAGLANDIN E2 (PGE2) RECEPTORS MODULATORS | MEDIBIOFARMA S L (ES) | 2026-01-14 | — | — | EP | disclosed |
| US-12509423-B2 | Compound, aldehyde dehydrogenase 2 activating agent, pharmaceutical composition, and therapeutic and/or prophylactic drug | ALCHEMEDICINE, INC. (JP) | 2025-12-30 | — | — | US | disclosed |
| EP-4660182-A1 | NAV1.7- AND/OR NAV1.8-INHIBITING ARYL PYRIDINE COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS | Eurofarma Laboratórios S.A. (BR) | 2025-12-10 | — | — | EP | disclosed |
| US-20250368634-A1 | PHENYL AMIDE COMPOUNDS AND METHODS OF USE | SCHRÖDINGER, INC. (US) | 2025-12-04 | — | — | US | disclosed |
| WO-2025243042-A1 | COMPOUNDS FOR THE INHIBITION OF CYCLOPHILIN D | THE UNIVERSITY OF LIVERPOOL (GB) | 2025-11-27 | — | — | WO | disclosed |
| CN-1168887-A | Method for preparing 5-bromo-2-fluorobenzeneboronic acid | AMERICAN CYANAMID CO (US) | 1997-12-31 | — | — | CN | disclosed |
| EP-0789688-A4 | INDOLYL NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | LILLY CO ELI (US) | 1997-11-19 | — | — | EP | disclosed |
| EP-0789688-A1 | INDOLYL NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1997-08-20 | — | — | EP | disclosed |
| WO-1997009308-A1 | INDOLYL NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1997-03-13 | — | — | WO | disclosed |
| EP-0295833-A1 | Aromatic-Spiropiperidine oxazepinones (and thiones) | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) (US) | 1988-12-21 | — | — | EP | disclosed |
| US-4746655-A | ANTIHISTAMINES | A. H. ROBINS COMPANY, INCORPORATED (US) | 1988-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509423-B2 | Compound, aldehyde dehydrogenase 2 activating agent, pharmaceutical composition, and therapeutic and/or prophylactic drug | ALDH2, ALDH1A1, ADH1A | KDM4E 3876/4885GLA 1137/4885DGAT1 352/4885 |
| US-20250368634-A1 | PHENYL AMIDE COMPOUNDS AND METHODS OF USE | AADAC, DBI, ASNS | KDM4E 1995/4885GLA 2518/4885DGAT1 3035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.